ceftizoxime
- 网络头孢唑肟;头孢克肟;头孢肟唑;头孢噻肟、头孢唑肟;头孢去甲噻肟
-
Study on the treatment of severe and difficult infections with ceftizoxime
头孢唑肟治疗严重与难治性感染的临床研究
-
Stability of ceftizoxime compatibility with six kinds of injection in transfusion
头孢唑肟在输液中与6种注射剂配伍的稳定性研究
-
Investigation of the compatible stability ceftizoxime sodium for injection in compound amino acid injection
注射用头孢唑肟钠在复方氨基酸注射液中稳定性的研究
-
A clinical study of ceftizoxime in the treatment of severe infections and gonorrhea
头孢唑肟治疗重症和难治性感染及淋球菌感染的临床研究
-
The dosage and route of administration of ceftizoxime in severe pulmonary infection
头孢唑肟治疗重症肺部感染用药剂量和用药途径的探讨
-
61 cases of severe and difficult bacterial infections were treated with ceftizoxime .
用头孢唑肟治疗严重与难治性细菌感染61例,其中肺部感染18例。
-
Evaluation of the Efficacy of Ceftizoxime Sodium Intravenous Administration in Low Respiratory Tract Bacterial Infection
注射用头孢唑肟钠治疗下呼吸道细菌感染的研究
-
Comparing the Content of Ceftizoxime Sodium Injection by HPLC with that by Microorganisms
HPLC与微生物法测定注射用头孢唑肟钠含量的比较
-
Ceftizoxime Injection vs. Cefotaxime Injection for Lower Respiratory Tract Infection : Cost-effective Analysis
注射用头孢唑肟和头孢噻肟治疗下呼吸道感染的成本-效果分析
-
Observation on stability of compatibility between ceftizoxime sodium for injection and ribavirin injection
注射用头孢唑肟钠与利巴韦林注射液配伍的稳定性考察
-
Ceftizoxime therapy in severe infectious complications of hematological malignancies in 24 patients
头孢唑肟治疗恶性血液病并发的重症感染24例
-
Multicentre clinical study on ceftizoxime sodium intravenous injection for treatment of respiratory and urinary tract infection
头孢唑肟钠注射剂治疗呼吸和泌尿系统感染多中心临床研究
-
Conclusion Treatment low respiratory tract bacterial infections with injection ceftizoxime sodium ( made in China ) is safe and effective .
结论注射用头孢唑肟钠(国产)治疗下呼吸道细菌感染安全有效。
-
Pharmacokinetics and tissue concentration of ceftizoxime in dogs
头孢唑肟在犬体内的组织浓度及药代动力学
-
Comparison of ceftizoxime stability with other 14 β - lactams to β - lactamases
比较头孢唑肟与其他14种β内酰胺类抗生素对β内酰胺酶的稳定性
-
Aim : To study the synthesis of ceftizoxime alapivoxil analogues and to search for new-type prodrug of ceftizoxime .
前言:目的:研究头孢唑肟丙匹酯类似物的合成,寻找新的头孢唑肟前药。
-
Method : 86 cases of pneumonia patients were divided into the ceftizoxime sodium group and the cefuroxime sodium group . The cost-effectiveness relation was evaluated with the method of pharmacoeconomics cost-effectiveness analysis .
方法:将86例肺炎患儿随机分为头孢唑肟钠治疗组和头孢呋辛钠治疗组,运用药物经济学的成本-效果分析方法进行比较。
-
OBJECTIVE : To study the stability of ceftizoxime ( CZX ) mixed with vitamin B 6 etc. in 5 % glucose injection solution , and provide a scientific basis for rationalized use of CZX .
目的:研究头孢唑肟(Ceftizoxime,CZX)在5%葡萄糖输液中与维生素B6等6种注射剂配伍的稳定性,为临床合理用药提供科学依据。
-
Object evaluate the efficacy and the safety of ceftizoxime sodium intravenous administration ( made in China ) for treatment of low respiratory tract bacterial infection compared with Epocelin ( injection with ceftizoxime sodium , imported raw materials ) .
目的以益保世灵(注射用头孢唑肟钠,进口原料)为对照,评价注射用头孢唑肟钠(国产)治疗下呼吸道细菌感染的疗效和安全性。
-
Objective To compare the stability of ceftizoxime and other 14 β - lactams to β - lactamases , especially CTX-M type extended-spectrum β - lactamases and provide reference information for clinical rational choice of β - lactams .
目的研究头孢唑肟对β内酰胺酶,特别是对CTX-M型超广谱酶的稳定性,并与临床常用β内酰胺抗生素比较。
-
Clinical efficacy rate and bacterial eradication rate for cefotaxime was separately 85.25 % and 86.00 % . The incidence of adverse reaction including whole clinical reactions and laboratory abnormalities was 6.06 % for ceftizoxime group and 7.81 % for cefotaxime group .
细菌清除率分别为85.19%和86.00%,药物不良反应发生率分别为6.06%和7.81%。
-
Methods 42 cases of low respiratory tract bacterial infection patients randomly divided into two groups ( observer group and control group ), the observer group was administrated ceftizoxime sodium ( made in China ) and control group was administrated Epocelin , regimens 7 ~ 14 days .
方法42例下呼吸道细菌感染患者随机分入观察组和对照组,观察组给予注射用头孢唑肟钠粉针剂(国产)治疗,对照组给予益保世灵治疗,疗程7~14天。